tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Schwartz, 48 are a HOLD (18.53%), 205 are a BUY (79.15%), 6 are a SELL (2.32%).
Analyst Joseph Schwartz, carries an average stock price target met ratio of 60.2% that have a potential upside of 51.82% achieved within 373 days. Previously, Joseph Schwartz worked at LEERINK.
Joseph Schwartz’s has documented 515 price targets and ratings displayed on 49 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on RNA, Avidity Biosciences at 27-Oct-2025.
Analyst best performing recommendations are on LRMR (LARIMAR THERAPEUTICS).
The best stock recommendation documented was for LRMR (LARIMAR THERAPEUTICS) at 12/1/2015. The price target of $132 was fulfilled within 1 day with a profit of $59.16 (30.95%) receiving and performance score of 309.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$13.75
$14
5 years 2 months 25 days ago
(05-Oct-2020)
13/18 (72.22%)
$0.67 (5.12%)
50
Buy
$13.75
$14
5 years 2 months 28 days ago
(02-Oct-2020)
5/7 (71.43%)
$0.01 (0.07%)
130
Hold
$10
$-3.75 (-27.27%)
$13
5 years 4 months 12 days ago
(18-Aug-2020)
6/8 (75%)
$-0.63 (-5.93%)
126
Buy
$10
$-3.75 (-27.27%)
$14
5 years 4 months 12 days ago
(18-Aug-2020)
1/5 (20%)
$-0.63 (-5.93%)
6
Hold
5 years 4 months 23 days ago
(07-Aug-2020)
0/3 (0%)
$17.19 (61.81%)
Which stock is Joseph Schwartz is most bullish on?
Which stock is Joseph Schwartz is most reserved on?
What Year was the first public recommendation made by Joseph Schwartz?
